Expression of CD33 is a predictive factor for effect of gemtuzumab ozogamicin at different doses in adult acute myeloid leukaemia

UK NCRI-AML Study Group, Naeem Khan, Robert Hills, P Virgo, S. Couzens, N Clark, A Gilkes, P Richardson, Steven Knapper, David Grimwade, N. H. Russell, AK Burnett, Sylvie Freeman

Research output: Contribution to journalArticlepeer-review

49 Citations (Scopus)
240 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Expression of CD33 is a predictive factor for effect of gemtuzumab ozogamicin at different doses in adult acute myeloid leukaemia'. Together they form a unique fingerprint.

Medicine & Life Sciences